Extended Data Fig. 1: Time course of N- and C- terminal RBD fusions.
From: Engineered LwaCas13a with enhanced collateral activity for nucleic acid detection
a and b, Background-subtracted fluorescence in the detection of 10 pM synthetic SARS-CoV-2 N gene fragment targets (T1) using N- (a) and C- (b) terminal RBD fusions, expressed as mean ± s.e.m. from four technical replicates.
